Website Operators Warned by FDA/DEA Offered Antibiotics, Cancer & HIV Treatments in Addition to Misbranded Opioids

On September 30th, the U.S. Food and Drug Administration (FDA) and the Drug Enforcement Administration (DEA) issued a joint warning to four online networks that were operating a total of ten fake online pharmacy websites. While all four networks were offering misbranded/counterfeit opioid medications such as tramadol and Soma for sale, three of the online networks had marketplaces offering misbranded medications to treat a kaleidoscope of ailments, such as allergies, cancer, smoking, asthma, and infection.

[...]

Canadians Concerned About US Prescription Drug Importation Proposals

John Adams of the Best Medicines Coalition, a Canadian group that represents 28 different patient organizations, has described the Trump administration’s plan to import medication from Canada as a “clear and present danger” to the Canadian prescription drug system, according to AP.

[...]

Keeping The Drug Supply Chain Safe Keeps Patients Safe

In a statement from the U.S. Food and Drug Administration, Commissioner Scott Gottlieb, M.D. discussed the agency’s continuing efforts to combat the spread of illicit opioids and to ensure the security of America’s drug supply chain. Included in their recent efforts, Commissioner Gottlieb noted that the agency has stepped up enforcement and interdiction work at International Mail Facilities and shut down websites illegally selling potentially dangerous, unapproved, and misbranded versions of opioid medications to U.S. citizens…

[...]

Doctor Robs Woman of Sight with Unapproved Stem Cell Treatment

Hoping to save her failing vision, a retired woman underwent what turned out to be a non-FDA approved treatment at a stem cell clinic in Georgia in September 2016. By December of that year, both of her retinas had detached, leaving her permanently blinded…

[...]